Diabetes care platform BeatO raises $33M from Lightrock, Flipkart Ventures
Diabetes care providerhas raised $33 million in Series B funding led by Lightrock India, with participation from HealthQuad and existing investors such as Orios Venture Partners, Blume Ventures, and Leo Capital.
Ecommerce giant's investment arm Flipkart Ventures has also invested an undisclosed amount in this round.
The fresh funding will be utilised to scale the digital platform, invest further in product, and strengthen the reach of BeatO's evidence-based care programs, the company said in a statement. The startup previously raised multiple rounds of debt funding from funds including Alteria Capital, W Health Global, and Kotak Investment Advisors.
Founded by Gautam Chopra, Yash Sehgal, and Kunal Kinalekar, BeatO is an app-based platform that provides diabetes care programs to prevent, control, and reverse diabetes. It also includes smartphone-connected glucometers to help with personalised health insights and access to medical experts.
India is set to overtake China to become the diabetes capital of the world, with over 200 million people across age groups at risk.
BeatO said it serves over 15 lakh customers with more than 70% of its customers from tier II cities. The company has grown 3x in the last year and is expected to close partnership deals with players from the insurance and pharmaceutical sectors soon. It also aims to expand its patient base to 10 million by 2025.
“With our digital first solution, BeatO is well positioned to lay the new standards of how care will be delivered in the future to millions of Indians. We are pleased to have a fantastic set of partners joining us on the journey who deeply resonate with our vision and bring solid capabilities to help us achieve our goal," Gautam Chopra, Co-Founder and CEO of BeatO said.
“BeatO is on an ambitious mission to re-design how diabetes is cared for in India. They are a world-class team that have demonstrated the ability to deliver consistent, high-quality and empathetic care resulting in clinical outcomes that are outstanding,” said Tejasvi Ravi, healthcare investments lead at Lightrock India.
(The story has been updated to add that Flipkart's investments arm Flipkart Ventures has invested in the funding round)
Edited by Megha Reddy